Optimizing outcomes for patients with severe haemophilia A

Haemophilia. 2007 Nov:13 Suppl 4:1-16; quiz 3 p following 16. doi: 10.1111/j.1365-2516.2007.01552.x.
No abstract available

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Catheters, Indwelling / adverse effects
  • Child
  • Coagulants / administration & dosage*
  • Coagulants / economics
  • Costs and Cost Analysis
  • Factor VIII / administration & dosage*
  • Factor VIII / economics
  • Hemarthrosis / economics
  • Hemarthrosis / prevention & control
  • Hemophilia A / economics
  • Hemophilia A / prevention & control*
  • Humans
  • Patient Transfer
  • Quality of Life
  • Recurrence
  • Refusal to Treat
  • Treatment Outcome
  • Treatment Refusal

Substances

  • Coagulants
  • Factor VIII